Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|October 25, 2021
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated DiseasesXinle Cui, Clifford M SnapperHuman Vaccines & Immunotherapeutics|April 25, 2019
Development of novel vaccines against human cytomegalovirusXinle Cui, Clifford M SnapperThe Journal of Biological Chemistry|May 16, 2003
An aminopeptidase, ARTS-1, is required for interleukin-6 receptor sheddingXinle Cui, Farshid N Rouhani, Feras Hawari, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 sheddingXinle Cui, Farshid N Rouhani, Feras Hawari, et al.Vaccines|April 3, 2021
Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV ChallengeXinle Cui, Zhouhong Cao, Yuriko Ishikawa, et al.Vaccine|June 14, 2016
Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350Xinle Cui, Zhouhong Cao, Quanyi Chen, et al.Vaccines|April 17, 2020
Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing ActivitiesXinle Cui, Zhouhong Cao, Shuishu Wang, et al.International Journal of Molecular Sciences|July 3, 2019
Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization ActivityXinle Cui, Zhouhong Cao, Shuishu Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|January 28, 2004
Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptorsFeras I Hawari, Farshid N Rouhani, Xinle Cui, et al.Cellular Microbiology|January 26, 2007
Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14Can Kocabas, Nora Katsenelson, Sunita Kanswal, et al.Pageof 2